Natus Neuro News and Activities

Natus Neuro is owned by Archimed Group. Archimed Group has a direct presence in 5 countries.

Archimed Group has 9 subsidiaries including EBI, Groupe Stago and HemoSonics.

They are in:

• Medical Equipment40%
• Pharmaceuticals40%
• Other20%

Acquisition, funding and merger involving Archimed Group.

• Archimed Group has acquired Groupe Stago (posted on May 4 2026).

View the org chart displaying its 16 main executives

Most searched biographies at Natus Neuro

• Chris Landon, Chief Executive Officer
• Seán Langan, Vice President, Global Operations
• Michael Owens, Chief Technology Officer

Popular executive movements at Natus Neuro

• Michael Owens has joined the company as Chief Technology Officer  (posted on March 24 2026).

Create your alert
to follow the executive moves at Natus Neuro.

Archimed Group has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Natus Neuro

Social media about Natus Neuro

• Natus Neuro on Wikipedia, Google News & Yahoo Finance
• Natus Neuro on LinkedIn, X (Twitter) & YouTube